These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20567997)

  • 1. Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.
    Zanella A; Gandin V; Porchia M; Refosco F; Tisato F; Sorrentino F; Scutari G; Rigobello MP; Marzano C
    Invest New Drugs; 2011 Dec; 29(6):1213-23. PubMed ID: 20567997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
    Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
    Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cu
    Bykowska A; Komarnicka UK; Jeżowska-Bojczuk M; Kyzioł A
    J Inorg Biochem; 2018 Apr; 181():1-10. PubMed ID: 29348049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
    Marzano C; Gandin V; Pellei M; Colavito D; Papini G; Lobbia GG; Del Giudice E; Porchia M; Tisato F; Santini C
    J Med Chem; 2008 Feb; 51(4):798-808. PubMed ID: 18251492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPP-related mitochondrial targeting copper (II) complex induces p53-dependent apoptosis in hepatoma cells through ROS-mediated activation of Drp1.
    Shao J; Li M; Guo Z; Jin C; Zhang F; Ou C; Xie Y; Tan S; Wang Z; Zheng S; Wang X
    Cell Commun Signal; 2019 Nov; 17(1):149. PubMed ID: 31744518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
    Santini C; Pellei M; Papini G; Morresi B; Galassi R; Ricci S; Tisato F; Porchia M; Rigobello MP; Gandin V; Marzano C
    J Inorg Biochem; 2011 Feb; 105(2):232-40. PubMed ID: 21194623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the introduction of a triphenylphosphine group on the anticancer activity of a copper complex.
    Li S; Zhao J; Guo Y; Mei Y; Yuan B; Gan N; Zhang J; Hu J; Hou H
    J Inorg Biochem; 2020 Sep; 210():111102. PubMed ID: 32574870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cytotoxicity of copper(I) complexes of 1,2-bis(diphenylphosphino)ethane.
    Sanghamitra NJ; Phatak P; Das S; Samuelson AG; Somasundaram K
    J Med Chem; 2005 Feb; 48(4):977-85. PubMed ID: 15715467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.
    Porchia M; Benetollo F; Refosco F; Tisato F; Marzano C; Gandin V
    J Inorg Biochem; 2009 Dec; 103(12):1644-51. PubMed ID: 19822369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper(I)-Phosphine Polypyridyl Complexes: Synthesis, Characterization, DNA/HSA Binding Study, and Antiproliferative Activity.
    Villarreal W; Colina-Vegas L; Visbal G; Corona O; Corrêa RS; Ellena J; Cominetti MR; Batista AA; Navarro M
    Inorg Chem; 2017 Apr; 56(7):3781-3793. PubMed ID: 28290674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents.
    Acilan C; Cevatemre B; Adiguzel Z; Karakas D; Ulukaya E; Ribeiro N; Correia I; Pessoa JC
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):218-234. PubMed ID: 27773706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mixed-ligand copper(I) complexes: role of diimine ligands on cytotoxicity and genotoxicity.
    Gandin V; Porchia M; Tisato F; Zanella A; Severin E; Dolmella A; Marzano C
    J Med Chem; 2013 Sep; 56(18):7416-30. PubMed ID: 23964823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer potency of copper(II) complexes of thiosemicarbazones.
    Singh NK; Kumbhar AA; Pokharel YR; Yadav PN
    J Inorg Biochem; 2020 Sep; 210():111134. PubMed ID: 32673842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
    Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
    J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
    Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
    Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(i) complexes with phosphine derived from sparfloxacin. Part III: multifaceted cell death and preliminary study of liposomal formulation of selected copper(i) complexes.
    Kyzioł A; Cierniak A; Gubernator J; Markowski A; Jeżowska-Bojczuk M; Komarnicka UK
    Dalton Trans; 2018 Feb; 47(6):1981-1992. PubMed ID: 29345262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Square planar Au(III), Pt(II) and Cu(II) complexes with quinoline-substituted 2,2':6',2″-terpyridine ligands: From in vitro to in vivo biological properties.
    Choroba K; Machura B; Szlapa-Kula A; Malecki JG; Raposo L; Roma-Rodrigues C; Cordeiro S; Baptista PV; Fernandes AR
    Eur J Med Chem; 2021 Jun; 218():113404. PubMed ID: 33823390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
    Gandin V; Trenti A; Porchia M; Tisato F; Giorgetti M; Zanusso I; Trevisi L; Marzano C
    Metallomics; 2015 Nov; 7(11):1497-507. PubMed ID: 26190698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.